Cafepharma Today

March 8 2021 - Stimulus bill packs a windfall for FDA and COVID-19 drug developers
Stimulus bill packs a windfall for FDA and COVID-19 drug developers
Roche nixes Tecentriq bladder cancer accelerated approval
AI uncovers Lilly's Olumiant as potential Alzheimer's treatment
Martin Shkreli faces another lawsuit
*please scroll down for all the latest news*

Stay updated with the latest pharma-related coronavirus news on our new page

Today's most popular searches:

Current News

submit a press release

Click here to stay updated on CP happenings
Countering payers, drugmakers say net prices declined in 2020
BioPharma Dive
Monday, March 8, 2021 - 9:32pm
tags:
drug pricing, payers
Merck reports positive early data for its experimental COVID-19 pill
Beckers Hospital Review
Monday, March 8, 2021 - 9:30pm
tags:
Merck, Ridgeback Biotherapeutics, COVID-19, clinical trials
Crucial data on AstraZeneca's vaccine are coming. Here's what we may learn.
BioPharma Dive
Monday, March 8, 2021 - 9:26pm
tags:
AstraZeneca, COVID-19, vaccines
Merck discard jumps straight to the top of the chart of the most expensive drugs in the US at $1M-plus
Endpoints
Monday, March 8, 2021 - 9:24pm
tags:
Eiger Pharmaceuticals, Merck, progeria, Prokinvy
GlaxoSmithKline's doctor payments double as relaxed policy plays out
Fierce Pharma
Monday, March 8, 2021 - 9:21pm
tags:
GSK, physicians, physician payments
CDC says fully vaccinated Americans can spend time together indoors and unmasked
Stat
Monday, March 8, 2021 - 9:19pm
tags:
COVID-19, vaccines, CDC
Biotech IPO market looks to ramp back up as BMS partner Ikena and its immunometabolism therapies eye public offering
Endpoints
Monday, March 8, 2021 - 9:15pm
tags:
IPOs, Ikena Oncology, Kyn Therapeutics, NASDAQ
Valneva and Pfizer start new Phase 2 study for Lyme disease vaccine candidate
Biopharma Reporter
Monday, March 8, 2021 - 9:14pm
tags:
Pfizer, Valneva, clinical trials, Lyme disease, VLA15
Stimulus bill packs a windfall for FDA and Covid-19 drug, vaccine developers
Endpoints
Monday, March 8, 2021 - 11:15am
tags:
legislative, stimulus, COVID-19, vaccines, drug development
New COVID-19 vaccine candidate leveraging nanotechnology is ‘promising’
Biopharma Reporter
Monday, March 8, 2021 - 11:14am
tags:
Cleveland Clinic, nanotechnology, vaccines, COVID-19
Roche joins the FDA accelerated approval revamp team, nixing a Tecentriq bladder cancer nod
Fierce Pharma
Monday, March 8, 2021 - 11:12am
tags:
Roche, Tecentriq, bladder cancer
CytoDyn digs deep for signs of efficacy in COVID-19 trial flop
Fierce Biotech
Monday, March 8, 2021 - 11:10am
tags:
CytoDyn, leronlimab, clinical trials, COVID-19
Baxter to provide sterile manufacturing, packaging for Moderna's COVID-19 vaccine
Marketwatch
Monday, March 8, 2021 - 11:09am
tags:
Baxter International, Moderna Therapeutics, drug manufacturing, vaccines, COVID-19
Gilead's Biktarvy build its case for long-term use with 4-year data showing lasting HIV suppression
Endpoints
Monday, March 8, 2021 - 11:04am
tags:
Gilead Sciences, Biktarvy, HIV
AI uncovers Eli Lilly's rheumatoid arthritis drug Olumiant as potential Alzheimer's treatment
Fierce Biotech
Monday, March 8, 2021 - 10:42am
tags:
Eli Lilly, olumiant, JAK inhibitors, artificial intelligence, Alzheimer's disease
COVID-19 drug doesn't benefit patients with mild illness, study finds
Beckers Hospital Review
Monday, March 8, 2021 - 10:41am
tags:
ivermectin, clinical trials, COVID-19
FDA approval brings remote programming for Abbott’s deep brain stimulation device
MedCity News
Monday, March 8, 2021 - 10:36am
tags:
devices, Abbott Labs, NeuroSphere, deep brain stimulation
Martin Shkreli faces another lawsuit, this time from insurer, alleging plans to create a monopoly for Daraprim
Endpoints
Monday, March 8, 2021 - 10:34am
tags:
Martin Shkreli, Daraprim
Will the U.S. have Covid vaccine doses for everyone by the end of May? Probably
Stat
Monday, March 8, 2021 - 10:33am
tags:
vaccines, COVID-19
Johnson & Johnson’s Covid-19 vaccine receives interim order authorization in Canada
Pharmaceutical Business Review
Monday, March 8, 2021 - 10:31am
tags:
JNJ, Canada, vaccines, COVID-19

Pages

Latest CP Wire Articles

“Special Fraud Alert” Targets Pharma & Medical Device Speaker Programs
Launch of Unprecedented Biotech Data Resource
Bigfinite is Now Aizon
SIFI reports positive results from 044/si phase 3 clinical trial further highlighting strength of its NETILDEX® franchise
Highlights: 2020 Cardiometabolic Health Congress West Live Online
Chelation Partners Announces Issuance of U.S. Patent Covering Composition of Matter for DIBI and Related Compounds for Controlling Infections
How Contingency Fee Arrangements Empower Whistleblowers
COVID-19 Employment and Whistleblower Issues - Interview With an Employment Attorney
Active Symptom Monitoring Won’t be Effective in Controlling Spread of COVID-19 Once World Returns to “New Normal,” Study Suggests
Cybersecurity, Pharma, and Whistleblowing

Latest Pharmagather Articles

The Importance of Immediate Drug Price Transparency
Drug Channels
Molnupiravir: Last of the Small-Molecule Coronavirus Hopes?
In the Pipeline
NEW: Drug Channels Quarterly Update: Patients, Payers, and PBMs (Live Video Webinar)
Drug Channels
How to Administer RNA – And How to Do It Again
In the Pipeline
Early March Vaccine Thoughts
In the Pipeline
Supermarkets Outpace CVS and Walgreens in 2021’s Part D Pharmacy Networks
Drug Channels
phactMI: Delivering accurate drug information to point of care
Elsevier
A Malaria Vaccine Candidate
In the Pipeline
Vetiver
In the Pipeline

Pharma and Device News from NASDAQ

Athira Pharma Announces Appointment of Barbara Kosacz to its Board of Directors
Monday, March 8, 2021 - 7:00am
Insights on the Nephrology Devices Global Market to 2025 - Impact of COVID-19 with Ansoff Analysis
Monday, March 8, 2021 - 6:58am
CytoDyn to Release CD12 Trial Detailed Results via Form 8-K After Investment Community Webcast, Monday, March 8
Monday, March 8, 2021 - 6:10am
CytoDyn to File Accelerated Rolling Review with MHRA and Interim Order (IO) with Health Canada for COVID-19
Monday, March 8, 2021 - 6:05am
CytoDyn’s Phase 3 Trial Demonstrates Safety, a 24% Reduction in Mortality and Faster Hospital Discharge for Mechanically Ventilated Critically Ill COVID-19 Patients Treated with Leronlimab
Monday, March 8, 2021 - 6:00am
CytoDyn to File Accelerated Rolling Review with MHRA and Interim Order (IO) with Health Canada for COVID-19
Saturday, March 6, 2021 - 8:40pm
CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and Regulatory Path Forward with the U.S., U.K., Canada, Philippines and Brazil
Friday, March 5, 2021 - 6:29pm
CytoDyn’s Phase 3 Trial Demonstrates Safety, a 24% Reduction in Mortality and Faster Hospital Discharge for Mechanically Ventilated Critically Ill COVID-19 Patients Treated with Leronlimab
Friday, March 5, 2021 - 5:47pm
AnPac Bio Regains Compliance with Nasdaq Continued Listing Requirement
Friday, March 5, 2021 - 4:35pm
Corvus Pharmaceuticals Announces Participation in Upcoming Investor Conferences
Friday, March 5, 2021 - 8:30am

Want to host your own webinar?

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information